Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether a single injection of Dysport with a new protocol at forearm is effective in the management of chronic lateral epicondylitis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tehran University of Medical Sciences
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• Pain: pain will be assessed as the physician touches lateral epicondyle or passively flexing the patient's wrist and while the patient extends his/her wrist or 3rd finger against resistance. Individuals who fulfill two or more of above will be considered to have lateral epicondylitis.

• Symptom duration: should be at least 6 months.

• Previous trial of complete course of physiotherapy and corticosteroid injection.

Exclusion Criteria:

• Rheumatoid arthritis

• Generalized polyarthritis

• Local elbow arthritis

• Simultaneous medial epicondylalgia

• Bilateral lateral epicondylitis

• Neurologic deficits (abnormal light touch sensation, deep tendon reflexes abnormality, radicular pain, radial nerve entrapment, signs of nerve root compression, decreased muscle force, multiple sclerosis, seizures)

• The use of corticosteroid in last 30 days

• Simultaneous use of drugs other than acetaminophen or physical therapy in the course of study

• Pregnancy

• Breast-feeding

• Previous hand surgery

• Having a hobby or job that needs finger extension